Polaryx Therapeutics, Inc. (PLYX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-09-14 | 8-K | Shareholder Vote Results | SEC |
| 2026-09-01 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-21 | 8-K | Officer / Director Changes | SEC |
| 2026-07-17 | 8-K | Item 5.08, Other Events | SEC |
| 2026-05-28 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov. “Webcast” links are the earnings-call webcast addresses stated in the company’s press release, and “IR page” links are the investor-relations pages the release points to; replays are typically available for a limited time. Earnings-call times are taken from the same press release and shown in the US time zone it states (ET, CT, MT or PT).